The Visera Digital Visual Imaging and Information platform from Olympusallows the physician to specialize each procedure while maintaining standardizationon the platform, creating greater operating efficiency for operating roomstaff and surgeons. The system can be upgraded to match the changing anddiverse needs of a facility's medical staff by adding build-on-demand moduleseven after the unit has been purchased and installed.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.